Skip to Content

France Eases Restrictions on Human Embryo Research

With embryonic stem cells in clinical trials in the U.S. and the U.K., France looks to keep up.

ScienceInsider reports that the French National Assembly approved a new law on Tuesday that could facilitate researchers’ ability to work with human embryos and embryonic stem cells.  

The existing law did allow French researchers to do some work with embryos, but was restrictive and required researchers to apply for permission to work with embryos; scientists had to show regulators that there was no other source of cells for their experiments and that the work could yield important medical discoveries. Proponents of the new law say the existing permit process enabled opponents of embryonic work to block research proposals; critics argue that the 190 approved applications between 2004 and 2012 demonstrate the old law was not a real hindrance, reports ScienceInsider.

An American company, Advanced Cell Technology, is currently testing retinal cells derived from human embryonic stem cells as a treatment for degenerative eye diseases in the U.S. and the U.K.

Keep Reading

Most Popular

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

close up of baby with a bottle
close up of baby with a bottle

The baby formula shortage has birthed a shady online marketplace

Desperate parents just want to feed their babies. They’re having to contend with misinformation, price gouging, and scams along the way.

"Olive Garden" NFTs concept
"Olive Garden" NFTs concept

I tried to buy an Olive Garden NFT. All I got was heartburn.

Our newest issue spells out what you need to know about the dizzying world of digital money.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.